(Q74260794)
Statements
No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) (English)
J Y Cahn
M Labopin
J Sierra
D Blaise
J Reiffers
A Ferrant
L Bergmann
G Visani
J Cornelissen
T De Witte